Security · featured owners
AZN Astrazeneca PLC
Health Care SPONSORED ADR Equity among managers we track
AZN (Astrazeneca PLC) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.
No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.
SEC filings
Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | UPDATE ON SERENA-4 PHASE III TRIAL | Filing Doc | |
| 6-K | IMFINZI+IMDELLTRA IMPROVED OS IN SMALL CELL LUNG | Filing Doc | |
| 6-K | ETCAMAH APPROVED IN THE US FOR HR+ BREAST CANCER | Filing Doc | |
| 6-K | TOTAL VOTING RIGHTS | Filing Doc | |
| 6-K | ADMISSION OF FURTHER SECURITIES TO TRADING | Filing Doc | |
| 6-K | TAGRISSO + ORPATHYS IMPROVED PFS IN 1L EGFRM LUNG | Filing Doc | |
| 6-K | ASTRAZENECA COMPLETES AGREEMENT FOR ZEGFROVY | Filing Doc | |
| 6-K | DIRECTORATE CHANGE | Filing Doc | |
| 6-K | ENHERTU APPROVED IN EU FOR 1L HER2-POSITIVE MBC | Filing Doc | |
| 6-K | ADMISSION TO TRADING - EUR2.55 BILLION BOND OFFERING | Filing Doc | |
| 6-K | TEZSPIRE CROSSING TRIAL MET PRIMARY ENDPOINTS | Filing Doc | |
| 6-K | ASTRAZENECA PRICES A EUR2.55 BILLION BOND OFFERING | Filing Doc | |
| 6-K | DIRECTOR/PDMR SHAREHOLDING | Filing Doc | |
| 6-K | TAGRISSO+ORPATHYS IMPROVED PFS & OS IN EGFRM LUNG | Filing Doc | |
| 6-K | UPDATE ON EVOLVE-LUNG02 PHASE III TRIAL | Filing Doc | |
| 6-K | ENHERTU IMPROVED PFS IN 1L HER2M LUNG CANCER | Filing Doc | |
| 6-K | ADMISSION OF FURTHER SECURITIES TO TRADING | Filing Doc | |
| 6-K | TOTAL VOTING RIGHTS | Filing Doc | |
| 6-K | DATROWAY APPROVED IN EU FOR TNBC | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | SONE-VE IMPROVED SURVIVAL IN GASTRIC CANCERS | Filing Doc | |
| 6-K | UPDATE ON ULTOMIRIS PHASE III TRIAL IN HSCT-TMA | Filing Doc | |
| 6-K | ETCAMAH APPROVED IN THE EU FOR ER+ BREAST CANCER | Filing Doc | |
| 6-K | ASTRAZENECA LICENSES NOVEL EGFR INHIBITOR | Filing Doc | |
| 6-K | UPDATE ON CARDIO-TTRANSFORM PHASE III TRIAL | Filing Doc |
No filings match this filter.
ownership over time
filing count by report period · click a bar for that quarter’s holders